- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: glycogen replenishment
Total 278 results
-
Anwaar SaeedActuate Therapeutics Inc.; Incyte CorporationActive, not recruitingPancreatic AdenocarcinomaUnited States
-
Ultragenyx Pharmaceutical IncTerminatedGlycogen Storage Disease Type IIIUnited States, Netherlands
-
Genzyme, a Sanofi CompanyActive, not recruitingGlycogen Storage Disease Type IIFrance
-
Hospital de Clinicas de Porto AlegreConselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação Médica...CompletedGlycogen Storage Disease Type IBrazil
-
Technical University of MadridCompleted
-
Amicus TherapeuticsCompletedPompe Disease (Late-onset)United States, Australia, Korea, Republic of, Japan, Taiwan, Belgium, Slovenia, New Zealand, United Kingdom, France, Argentina, Canada, Spain, Bosnia and Herzegovina, Germany, Sweden, Hungary, Austria, Bulgaria, Denmark, Greece, I... and more
-
Insel Gruppe AG, University Hospital BernWithdrawn
-
University of FloridaEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Amicus TherapeuticsAvailablePompe Disease Infantile-OnsetTaiwan, United States, Italy
-
Amicus TherapeuticsAvailable
-
University of CincinnatiCompletedHypoglycemiaUnited States
-
Genzyme, a Sanofi CompanyActive, not recruitingGlycogen Storage Disease Type II-Pompe's DiseaseUnited States, France, Japan, Taiwan, United Kingdom
-
Asklepios Biopharmaceutical, Inc.Active, not recruiting
-
Ultragenyx Pharmaceutical IncTerminatedWilson Disease | Ornithine Transcarbamylase Deficiency | Glycogen Storage Disease Type IASpain, United Kingdom, Canada, United States, Brazil
-
Duke UniversityCompleted
-
Spark TherapeuticsCompletedLysosomal Storage Diseases | Glycogen Storage Disease Type 2 | Pompe Disease (Late-onset) | Pompe Disease | LOPD | Acid Maltase DeficiencyUnited States, Italy, United Kingdom, Netherlands, France, Germany
-
Genzyme, a Sanofi CompanyCompletedPompe Disease | Glycogen Storage Disease Type II (GSD II) | Acid Maltase DeficiencyUnited States, Belgium, Denmark, France, Germany, Netherlands, United Kingdom
-
Centre Hospitalier Universitaire de NiceCompleted
-
Rocket Pharmaceuticals Inc.Active, not recruitingDanon DiseaseUnited States
-
CENTOGENE GmbH RostockWithdrawnFructose Metabolism, Inborn Errors | Glycogen Storage Disease Type II | Glycogen Storage Disease | Glycogen Storage Disease Type V | Glycogen Storage Disease Type I | Glycogen Storage Disease Type III | Glycogen Storage Disease Type VII | Glycogen Storage Disease Type IV | Glycogen Storage Disease Type... and other conditionsGermany, India, Sri Lanka
-
Rigshospitalet, DenmarkUniversity College, LondonCompletedMcArdle DiseaseDenmark, United Kingdom
-
Nicoline LøkkenCompleted
-
Rigshospitalet, DenmarkCompleted
-
CENTOGENE GmbH RostockWithdrawnLung Disease | Cerebral Aneurysm | Macroglossia | Cardiac Diseases | Obstructive Sleep Apnoea | Muscular Weakness | Hepato-splenomegalyGermany, India, Sri Lanka
-
BioMarin PharmaceuticalTerminatedLate-onset Pompe DiseaseUnited States, United Kingdom
-
University of BirminghamDairy Management Inc.Completed
-
Ultragenyx Pharmaceutical IncCompletedGSD1Netherlands, United States, Canada, Spain
-
Liverpool John Moores UniversityAlliance for Potato Research and EducationCompletedEnergy Supply; Deficiency | Energy Balance | Energy AvailabilityUnited Kingdom
-
Mads Peter Godtfeldt StemmerikEdgewise Therapeutics, Inc.CompletedBecker Muscular Dystrophy | McArdle Disease | Limb-Girdle Muscular Dystrophy Type 2Denmark
-
Helga EllingsgaardCompletedGlycogen DepletionDenmark
-
Turkish Society of Pediatric Gastroenterology,...CompletedDuchenne Muscular Dystrophy | Pompe Disease (Late-onset)Turkey
-
Ionis Pharmaceuticals, Inc.CompletedLafora DiseaseUnited States, Italy, Spain
-
Ultragenyx Pharmaceutical IncCompletedGlycogen Storage Disease Type IIIUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Pompe DiseaseUnited States
-
LMU KlinikumCompletedHealthy | Myotonic Dystrophy Type 2 | Pompe Disease (Late-onset) | Spinal Muscular Atrophy Type 3 | Myotonic Dystrophy Type 1 (DM1) | Facioscapulohumeral Muscular Dystrophy 1 | Inclusion Body Myositis, SporadicGermany
-
Duke UniversityWithdrawnPompe Disease (Late-onset)United States
-
University of California, Los AngelesAIDS Healthcare FoundationCompleted
-
Erica GoldsteinCompletedDietary SupplementationsUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIChina
-
University Hospital Inselspital, BerneTentan AGCompletedBacterial VaginosisSwitzerland
-
Genzyme, a Sanofi CompanyTerminatedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease | Glycogenesis 2 Acid Maltase DeficiencyUnited States, Israel
-
University of FloridaLacerta TherapeuticsCompletedPompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedPompe Disease | Glycogen Storage Disease Type II (GSD II)United States, Russian Federation, United Kingdom, Bulgaria, India, Ukraine
-
University Medical Center GroningenUltragenyx Pharmaceutical IncCompletedGlycogen Storage Disease Type IANetherlands
-
Reneo Pharma LtdCompletedMcArdle DiseaseSpain, United Kingdom
-
Areeg El-GharbawyUltragenyx Pharmaceutical IncCompletedGlycogen Storage Disease Type IUnited States
-
Jerry Vockley, MD, PhDUltragenyx Pharmaceutical IncNo longer availableBarth Syndrome | Mitochondrial Trifunctional Protein Deficiency | Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency | Carnitine Palmitoyltransferase Deficiencies (CPT1, CPT2) | Long-chain Hydroxyacyl-CoA Dehydrogenase Deficiency | Glycogen Storage Disorders | Pyruvate Carboxylase Deficiency... and other conditionsUnited States
-
Duke UniversityCompleted